These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32845714)

  • 1. Clinical Importance of Incidental Homogeneous Renal Masses That Measure 10-40 mm and 21-39 HU at Portal Venous Phase CT: A 12-Institution Retrospective Cohort Study.
    Corwin MT; Altinmakas E; Asch D; Bishop KA; Boge M; Curci NE; Ebada M; Elkassem AA; Fananapazir G; Fetzer DT; Gaballah AH; Gandhi D; Kampalath R; Lee S; Markese M; McInnes MDF; Patel NU; Remer EM; Rosasco S; Schieda N; Sweet DE; Smith AD; Taylor E; Silverman SG; Davenport MS
    AJR Am J Roentgenol; 2021 Jul; 217(1):135-140. PubMed ID: 32845714
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of Solid Tumors in Incidentally Detected Homogeneous Renal Masses Measuring > 20 HU on Portal Venous Phase CT.
    Corwin MT; Hansra SS; Loehfelm TW; Lamba R; Fananapazir G
    AJR Am J Roentgenol; 2018 Sep; 211(3):W173-W177. PubMed ID: 29995501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Definition of a Benign Renal Cyst on Contrast-enhanced CT: Can Incidental Homogeneous Renal Masses Measuring 21-39 HU be Safely Ignored?
    Hu EM; Ellis JH; Silverman SG; Cohan RH; Caoili EM; Davenport MS
    Acad Radiol; 2018 Feb; 25(2):209-212. PubMed ID: 29174191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of malignant or possibly malignant renal masses among homogeneous low-attenuation masses that are too small to characterize at computed tomography.
    Qarni B; McGrath T; Aldhufian M; Schieda N
    Abdom Radiol (NY); 2023 Aug; 48(8):2628-2635. PubMed ID: 37166461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of Bosniak 2019 for renal mass classification on portal venous phase at the era of spectral CT imaging using rapid kV-switching dual-energy CT.
    Reizine E; Blain M; Pescatori L; Longère B; Ingels A; Boughamni W; Bouanane M; Mulé S; Luciani A
    Eur Radiol; 2024 Mar; 34(3):1816-1824. PubMed ID: 37667141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of class II cystic renal masses proposed in Bosniak classification version 2019: a systematic review of supporting evidence.
    McGrath TA; Shoeib A; Davenport MS; Silverman SG; McInnes MDF; Schieda N
    Abdom Radiol (NY); 2021 Oct; 46(10):4888-4897. PubMed ID: 34152438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding management.
    O'Connor SD; Pickhardt PJ; Kim DH; Oliva MR; Silverman SG
    AJR Am J Roentgenol; 2011 Jul; 197(1):139-45. PubMed ID: 21701022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Low-Attenuation Homogeneous Papillary Renal Cell Carcinoma Mimicking Renal Cysts on CT.
    Corwin MT; Loehfelm TW; McGahan JP; Liang C; Khati NJ; Haji-Momenian S
    AJR Am J Roentgenol; 2018 Dec; 211(6):1259-1263. PubMed ID: 30240301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.
    Loonis AT; Yu H; Glazer DI; Bay CP; Sodickson AD
    AJR Am J Roentgenol; 2023 May; 220(5):693-704. PubMed ID: 36416399
    [No Abstract]   [Full Text] [Related]  

  • 10. Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management.
    Narayanasamy S; Krishna S; Prasad Shanbhogue AK; Flood TA; Sadoughi N; Sathiadoss P; Schieda N
    Clin Radiol; 2019 Feb; 74(2):83-94. PubMed ID: 30314810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Bosniak Classification Version 2019 Class IIF Cystic Renal Masses at Imaging Surveillance.
    Shen L; Yoon L; Chung BI; Kamaya A; Tse JR
    AJR Am J Roentgenol; 2023 May; 220(5):705-717. PubMed ID: 36416398
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact Analysis of the Routine Use of Dual-Energy Computed Tomography for Characterization of Incidental Renal Lesions.
    Wortman JR; Shyu JY; Fulwadhva UP; Sodickson AD
    J Comput Assist Tomogr; 2019; 43(2):176-182. PubMed ID: 30475248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement Threshold of Small (< 4 cm) Solid Renal Masses on CT.
    Al Harbi F; Tabatabaeefar L; Jewett MA; Finelli A; O'Malley M; Atri M
    AJR Am J Roentgenol; 2016 Mar; 206(3):554-8. PubMed ID: 26901011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Lesion Characterization by Dual-Layer Dual-Energy CT: Comparison of Virtual and True Unenhanced Images.
    Cao J; Lennartz S; Pisuchpen N; Mroueh N; Kongboonvijit S; Parakh A; Sahani DV; Kambadakone A
    AJR Am J Roentgenol; 2022 Oct; 219(4):614-623. PubMed ID: 35441533
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
    Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
    Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma attenuation values on unenhanced CT: importance of multiple, small region-of-interest measurements.
    McGahan JP; Sidhar K; Fananapazir G; Early H; Corwin MT; Silverman SG; Seibert A
    Abdom Radiol (NY); 2017 Sep; 42(9):2325-2333. PubMed ID: 28389785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations.
    Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H
    AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT imaging of solid renal masses: pitfalls and solutions.
    Krishna S; Murray CA; McInnes MD; Chatelain R; Siddaiah M; Al-Dandan O; Narayanasamy S; Schieda N
    Clin Radiol; 2017 Sep; 72(9):708-721. PubMed ID: 28592361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of renal cell carcinomas from high-attenuation renal cysts at portal venous phase contrast-enhanced CT.
    Suh M; Coakley FV; Qayyum A; Yeh BM; Breiman RS; Lu Y
    Radiology; 2003 Aug; 228(2):330-4. PubMed ID: 12819331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Importance of Incidentally Detected Hyperenhancing Liver Observations on Portal Venous Phase Computed Tomography in Patients Without Known Malignancy or Liver Disease.
    Corwin MT; DiGeronimo RT; Navarro SM; Fananapazir G; Wilson M; Loehfelm TW
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):516-521. PubMed ID: 34519450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.